GSK Venture Capital Arm Goes Independent With $500m Fund
SR One Focused on Establishing Elite US And EU Biotechs
Having been under GSK's umbrella since 1985, SR One is striking out on its own, having closed the largest first-time VC fund this year.
Having been under GSK's umbrella since 1985, SR One is striking out on its own, having closed the largest first-time VC fund this year.